Research location
Great Neck
New York, United States
Advertisement
Research activity in Great Neck
New York, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 160 trials and 164 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Great Neck
160 linked trials · page 2 of 4Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)NCT02115750 · 2014-05-01 · 1 site observation
COMPLETED
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid ArthritisNCT02092467 · 2014-03-14 · 1 site observation
COMPLETED
Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic NephropathyNCT02065791 · 2014-02-17 · 1 site observation
COMPLETED
A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk FactorsNCT02019264 · 2014-01-24 · 1 site observation
COMPLETED
A Study in Participants With Asthma Initiating Treatment With Omalizumab (Xolair)NCT01922037 · 2013-06-19 · 1 site observation
COMPLETED
Using A Dissolved Oxygen Enriched Dressing in Nipple-sparing MastectomyNCT01796977 · 2012-12-01 · 1 site observation
TERMINATED
A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.NCT01727141 · 2012-11-01 · 1 site observation
COMPLETED
NVA237 BID Versus Placebo Twelve-week Efficacy StudyNCT01715298 · 2012-11-01 · 1 site observation
COMPLETED
Rheumatoid Arthritis Extension Trial For Subjects Who Have Participated In Other PF-05280586 Trials (REFLECTIONS B328-04)NCT01643928 · 2012-08-16 · 1 site observation
COMPLETED
Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)NCT01572792 · 2012-04-01 · 1 site observation
COMPLETED
A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To TNF Inhibitors (REFLECTIONS B328-01)NCT01526057 · 2012-03-20 · 1 site observation
COMPLETED
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)NCT01545440 · 2012-03-01 · 1 site observation
COMPLETED
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and AdolescentsNCT01444430 · 2011-12-01 · 1 site observation
COMPLETED
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years OldNCT01462344 · 2011-11-17 · 1 site observation
COMPLETED
Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)NCT01443845 · 2011-09-30 · 1 site observation
COMPLETED
Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)NCT01437397 · 2011-09-01 · 1 site observation
COMPLETED
Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)NCT01431287 · 2011-09-01 · 1 site observation
COMPLETED
Safety and Efficacy of LX4211 With Metformin in Type 2 Diabetes Patients With Inadequate Glycemic Control on MetforminNCT01376557 · 2011-06-01 · 1 site observation
COMPLETED
Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With GastroparesisNCT01262898 · 2011-05-03 · 1 site observation
COMPLETED
The Effect of Montelukast on Asthma Control in Overweight/Obese Atopic AsthmaticsNCT01329939 · 2011-04-01 · 1 site observation
COMPLETED
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary DiseaseNCT01313676 · 2011-01-25 · 1 site observation
COMPLETED
Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes MellitusNCT01191320 · 2010-10-01 · 1 site observation
COMPLETED
Comparison of Tiotropium in the HandiHaler Versus the Respimat in Chronic Obstructive Pulmonary DiseaseNCT01126437 · 2010-05-01 · 1 site observation
COMPLETED
Post Kidney Transplant Nocturnal Hypertension Prevalence and Management StudyNCT01120613 · 2010-04-01 · 1 site observation
WITHDRAWN
Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) ExacerbationsNCT01120691 · 2010-04-01 · 1 site observation
COMPLETED
JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With NatalizumabNCT01070836 · 2010-03-01 · 1 site observation
COMPLETED
Efficacy and Safety of Different Doses of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD)NCT01089127 · 2010-03-01 · 1 site observation
COMPLETED
Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or ProctosigmoiditisNCT01008423 · 2009-11-20 · 1 site observation
COMPLETED
ARI103094-Follow-Up Study for REDUCE Study SubjectsNCT00883909 · 2009-04-09 · 1 site observation
COMPLETED
Naturalistic Safety Registry Of Celecoxib (CELEBREX(R)) And NSAIDs In Juvenile Idiopathic ArthritisNCT00688545 · 2009-04-01 · 1 site observation
TERMINATED
Efficacy and Safety of Aclidinium Bromide for Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-33)NCT00891462 · 2009-04-01 · 1 site observation
COMPLETED
Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary DiseaseNCT00877383 · 2009-04-01 · 1 site observation
COMPLETED
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast CancerNCT00807859 · 2009-03-09 · 1 site observation
COMPLETED
Oral Cladribine in Early Multiple Sclerosis (MS)NCT00725985 · 2008-12-31 · 1 site observation
COMPLETED
Safety and Efficacy in Type 2 Diabetic Patients With Severe Chronic Renal Impairment, 5 mg BI 1356 (Linagliptin) vs. Placebo, Insulin Background InclusiveNCT00800683 · 2008-12-01 · 1 site observation
COMPLETED
Patient Transitioning From Exubera® Inhalation Powder to Technosphere® Insulin Inhalation PowderNCT01798914 · 2008-10-01 · 1 site observation
NO_LONGER_AVAILABLE
Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study II)NCT00776984 · 2008-10-01 · 1 site observation
COMPLETED
An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.NCT00696436 · 2008-04-01 · 1 site observation
COMPLETED
Immediate Postmastectomy Breast Reconstruction (Strattice Breast)NCT00619762 · 2007-10-01 · 1 site observation
COMPLETED
Safety and Effectiveness of 3 Doses of Crofelemer Compared to Placebo in the Treatment of HIV Associated DiarrheaNCT00547898 · 2007-10-01 · 1 site observation
COMPLETED
Cobiprostone Prevention of NSAID-induced Gastroduodenal InjuryNCT00597818 · 2007-08-01 · 1 site observation
COMPLETED
A Study of Exercise Endurance and Lung Hyperinflation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)NCT00500318 · 2007-07-01 · 1 site observation
COMPLETED
A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg BID In Symptomatic Subjects With AsthmaNCT00452699 · 2007-05-01 · 1 site observation
COMPLETED
Expanded Access Program for Maraviroc At Multiple CentersNCT00426660 · 2007-02-01 · 1 site observation
COMPLETED
A Study of the Safety of Rituxan in Patients With Rheumatoid Arthritis After an Inadequate Response to Previous Anti-TNF Therapy (SUNSTONE)NCT00443443 · 2007-01-01 · 1 site observation
COMPLETED
Multi-Center Human Alert Trial to Prevent DVT and PENCT00409136 · 2006-03-01 · 1 site observation
COMPLETED
Natalizumab Re-Initiation of DosingNCT00306592 · 2006-03-01 · 1 site observation
COMPLETED
Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast CancerNCT00320710 · 2006-02-01 · 1 site observation
COMPLETED
A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)NCT00257608 · 2006-01-01 · 1 site observation
COMPLETED
Observational Study Of An Electronic Questionnaire In Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT00259909 · 2005-11-02 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.